Te-Chang Lee

USPTO Granted Patents = 4 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 1

Company Filing History:

Memorial Sloan Kettering Cancer Center

patents

where one patent can have more than one assignee

Years Active: 2014-2021

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11066412 - Substituted pyrrolo[2,1-a]phthalazines and benzo[g]pyrrolo[2,1-a]phthalazines for the treatment of cancer (2021-07-20),

2. 10548861 - Use of ureidomustine (BO-1055) in cancer treatment (2020-02-04),

3. 8772284 - Method of treating cancer using combination of a bifunctional alkylating agent and DNA repair inhibitors (2014-07-08),

4. 8703951 - Synthesis of 4H-benzo[D]pyrrolo[1,2-A]thiazoles and indolizino[6,7-b]indole derivatives and their use as antitumor therapeutic agents (2014-04-22),

Title: Te-Chang Lee: Innovator in Cancer Treatment

Introduction

Te-Chang Lee is a prominent inventor based in Taipei, Taiwan, known for his significant contributions to cancer treatment through innovative compounds. With a total of four patents to his name, Lee has made strides in developing novel therapeutic agents aimed at combating various forms of cancer.

Latest Patents

Among his latest patents, Lee has disclosed novel bifunctional compounds, specifically substituted pyrrolo[2,1-a]phthalazines and benzo[g]pyrrolo[2,1-a]phthalazines. These compounds are designed for the treatment and/or prophylaxis of cancers. The structure of these bifunctional compounds includes various substituents, which enhance their efficacy in targeting cancer cells. Another significant patent involves the use of ureidomustine (BO-1055), a water-soluble NDA cross-linking agent, in treating several types of human leukemia, lymphomas, small lung cell carcinoma, and sarcomas.

Career Highlights

Te-Chang Lee has worked with esteemed institutions such as Academia Sinica and Memorial Sloan Kettering Cancer Center. His work in these organizations has allowed him to collaborate with leading experts in the field of cancer research, furthering his impact on medical science.

Collaborations

Lee has collaborated with notable colleagues, including Tsann-Long Su and Ting-Chao Chou, who have contributed to his research endeavors and the development of his patented compounds.

Conclusion

Te-Chang Lee's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. His patents reflect a commitment to finding effective solutions for challenging health issues.

This text is generated by artificial intelligence and may not be accurate.